PPA

Parametric Portfolio Associates Portfolio holdings

AUM $190B
1-Year Est. Return 18.52%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+18.52%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$195B
AUM Growth
+$19.5B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
3,778
New
Increased
Reduced
Closed

Top Buys

1
+$827M
2
+$218M
3
+$162M
4
AMZN icon
Amazon
AMZN
+$157M
5
AAPL icon
Apple
AAPL
+$138M

Top Sells

1
+$629M
2
+$189M
3
+$154M
4
KSU
Kansas City Southern
KSU
+$118M
5
MDT icon
Medtronic
MDT
+$99.3M

Sector Composition

1 Technology 25.12%
2 Financials 12.71%
3 Healthcare 12.46%
4 Consumer Discretionary 10.99%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTAI icon
3676
BioXcel Therapeutics
BTAI
$38.9M
– –
-720
BZUN
3677
Baozun
BZUN
$149M
– –
-89,531
CAAP icon
3678
Corporacion America
CAAP
$4.29B
– –
-151,231
CRCT icon
3679
Cricut
CRCT
$867M
– –
-68,663
CRDF icon
3680
Cardiff Oncology
CRDF
$126M
– –
-15,039
CWCO icon
3681
Consolidated Water Co
CWCO
$482M
– –
-12,383
DBVT
3682
DBV Technologies
DBVT
$1.12B
– –
-9,947
DNTH icon
3683
Dianthus Therapeutics
DNTH
$4.97B
– –
-950
EFAV icon
3684
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.31B
– –
-3,257
EOLS icon
3685
Evolus
EOLS
$433M
– –
-16,346
EPOL icon
3686
iShares MSCI Poland ETF
EPOL
$642M
– –
-110,691
GNLN icon
3687
Greenlane Holdings
GNLN
$2.12M
– –
0
IDV icon
3688
iShares International Select Dividend ETF
IDV
$8.57B
– –
-25,404
IGMS
3689
DELISTED
IGM Biosciences
IGMS
– –
-5,398
IQLT icon
3690
iShares MSCI Intl Quality Factor ETF
IQLT
$13.4B
– –
-5,804
IUSV icon
3691
iShares Core S&P US Value ETF
IUSV
$26.1B
– –
-13,431
JANX icon
3692
Janux Therapeutics
JANX
$899M
– –
-59,366
LXFR icon
3693
Luxfer Holdings
LXFR
$462M
– –
-10,573
MMYT icon
3694
MakeMyTrip
MMYT
$4.49B
– –
-16,855
NCNO icon
3695
nCino
NCNO
$1.74B
– –
-41,897
NEXA icon
3696
Nexa Resources
NEXA
$1.97B
– –
-14,855
ODC icon
3697
Oil-Dri
ODC
$1.15B
– –
-14,758
PHAT icon
3698
Phathom Pharmaceuticals
PHAT
$823M
– –
-13,640
PRLD icon
3699
Prelude Therapeutics
PRLD
$313M
– –
-10,130
PROV icon
3700
Provident Financial
PROV
$107M
– –
-11,346
146 147
148
149 150